Alliances
Utilizing AI technology to streamline information analysis and contribute to progress in an emergent, yet vital frontier of medical science
Under the terms of the deal with BBA, BBA acquired a capped 4.5% royalty on net sales of KSI-301 that will be paid upon marketing approval.
Beyond Air, Inc. announced an exclusive five-year global supply agreement for NO and NO2 calibration gas with MESA Specialty Gases & Equipment.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
The so-called “heart-in-a-jar” will be created from human stem cells and designed to reproduce key phenotypic characteristics of heart failure.
Inceptua and Bendalis enter into an exclusive oncology medicine supply agreement for clinical trials
The global pharmaceutical company and service partner Inceptua Group and Bendalis GmbH – German manufacturer of generic oncology drugs and special therapeutic agents, announce the signing of an exclusive clinical trial supply agreement for oncology generics.
BioSyent Inc. is pleased to announce that its subsidiary BioSyent Pharma Inc. has signed an exclusive License and Supply Agreement with AFT Pharmaceuticals for a portfolio of new pain management products for the Canadian market.
FerGene, a Ferring subsidiary, was created to commercialize the drug in the U.S. and advance global development.
The new facility, which could be open by the end of 2021, will be supported by Harvard University, Massachusetts Institute of Technology, GE Healthcare Life Sciences, Alexandria Real Estate Equities and FUJIFILM Diosynth Biotechnologies.
STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – and Impact Therapeutics, a biotech focused on innovative drug discovery and development in anti-cancer therapeutics, announce the signing of a strategic partnership agreement.
PRESS RELEASES